圣诺医药（股票代码：02257）于2026年2月4日发布截至2026年1月31日的证券变动月报表。公告显示，公司本月法定注册股本维持在230,000,000股，每股面值0.001美元，总额为230,000美元，保持不变。
本月普通股的已发行股份数为107,221,538股，无库存股份，期末与期初一致。公司未进行新增发行、购回或注销操作，亦无库存股变动。根据报告内容，公司公众持股量符合相关上市规则门槛。
期权与激励计划方面，圣诺医药于本月并无新增行使或失效情况。截至1月底，购股权计划持有的期权总数为731,679份，未发生行使或注销变动，相关受限制股份单位计划也未有新股发行。
公司确认所有发行及相关事宜均符合香港联交所《上市规则》的要求，并遵守了相关法律法规。公告由公司秘书袁润廷签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.